Literature DB >> 31443809

Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study.

José M Martínez-Ortega1, Paloma Nogueras2, José E Muñoz-Negro3, Luis Gutiérrez-Rojas4, Pablo González-Domenech5, Manuel Gurpegui1.   

Abstract

OBJECTIVE: To compare quality of life (QoL), anxiety and depressive symptoms, alcohol consumption and other correlates between patients with psoriasis and controls; and to identify features of psoriasis associated with lower levels of QoL.
METHOD: Case-control study including 70 subjects with moderate-severe psoriasis and 140 controls without psoriasis. All participants answered the Short Form Health Survey (SF-36), with physical and mental component scores of quality of life, and the Hospital Anxiety and Depression Scale (HADS). Among subjects with psoriasis, the Psoriasis Area and Severity Index (PASI) and the Dermatology Life Quality Index (DLQI) were used, respectively, to measure the severity of psoriasis and the impact of psoriasis on the specific quality of life.
RESULTS: Compared to controls, patients with psoriasis showed higher HADS depression score and alcohol consumption, and lower QoL. Among subjects with psoriasis, multivariate analysis showed: 1) poorer physical QoL was associated with older age, articular lesions and anxious symptoms, whereas poorer mental QoL was associated with younger age, female sex, genital lesions and depressive symptoms; 2) the higher the severity of psoriasis, the lower the level of QoL and the higher the levels of anxious or depressive symptoms; and 3) female sex and articular or genital location of lesions are linked with higher HADS scores.
CONCLUSION: Higher scores in anxiety and depression and lower QoL is common in psoriasis, especially among women and those with genital or articular lesions. Dermatologists should give special attention to this subgroup of persons with psoriasis in order to prevent future psychopathology.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31443809     DOI: 10.1016/j.jpsychores.2019.109780

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  13 in total

Review 1.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

2.  Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis.

Authors:  Isabelle Jalenques; Fabien Bourlot; Elisa Martinez; Bruno Pereira; Michel D'Incan; Sophie Lauron; Fabien Rondepierre
Journal:  Acta Derm Venereol       Date:  2022-08-26       Impact factor: 3.875

3.  Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting.

Authors:  Yitian Lang; Bin Wu; Zhilin Sun; Erjia Ye; Guanshen Dou; Xin Guan
Journal:  Patient Prefer Adherence       Date:  2022-04-21       Impact factor: 2.314

4.  Relationships between the acceptance of illness, quality of life and satisfaction with life in psoriasis.

Authors:  Beata Kowalewska; Barbara Jankowiak; Barbara Niedżwiecka; Elżbieta Krajewska-Kułak; Wiaczesław Niczyporuk; Dzmitry Fiodaravich Khvorik
Journal:  Postepy Dermatol Alergol       Date:  2020-02-11       Impact factor: 1.837

5.  Effect of Disease Severity on the Quality of Life and Sense of Stigmatization in Psoriatics.

Authors:  Beata Kowalewska; Barbara Jankowiak; Mateusz Cybulski; Elżbieta Krajewska-Kułak; Dzmitry Fiodaravich Khvorik
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-02

6.  The Assessment of Risk and Predictors of Sleep Disorders in Patients with Psoriasis-A Questionnaire-Based Cross-Sectional Analysis.

Authors:  Julia Nowowiejska; Anna Baran; Marta Lewoc; Paulina Grabowska; Tomasz W Kaminski; Iwona Flisiak
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

7.  Discovering Novel Biomarkers Associated with the Pathogenesis of Psoriasis: Evidence from Bioinformatic Analysis.

Authors:  Yang Yang; Shaoqiong Xie; Wencheng Jiang; Suwei Tang; Yuling Shi
Journal:  Int J Gen Med       Date:  2022-03-11

8.  D-Mannose Suppresses γδ T Cells and Alleviates Murine Psoriasis.

Authors:  Mingyang Li; Haiyan Cheng; Dan Tian; Lu Yang; Xiaonan Du; Yuhualei Pan; Dong Zhang; Xueling Mei
Journal:  Front Immunol       Date:  2022-02-28       Impact factor: 7.561

9.  The Impact of Stress-Coping Strategies and the Severity of Psoriasis on Self-Esteem, Illness Acceptance and Life Satisfaction.

Authors:  Beata Kowalewska; Elżbieta Krajewska-Kułak; Marek Sobolewski
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-18

Review 10.  Neuro-dermatological association between psoriasis and depression: an immune-mediated inflammatory process validating skin-brain axis theory.

Authors:  Shahzaib Maqbool; Arham Ihtesham; Muhammad Nadeem Langove; Sara Jamal; Tabdar Jamal; Hafiz Abu Safian
Journal:  AIMS Neurosci       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.